INVESTORS & MEDIA

Events & Presentations

Upcoming Events
Jun 142024 10:30 AM EDT Jun 14, 2024 | 10:30 AM EDT

The 2024 Annual Meeting of Shareholders of Regeneron Pharmaceuticals, Inc. will be held on Friday, June 14, 2024, commencing at 10:30 a.m., Eastern Time, virtually via the Internet at www.virtualshareholdermeeting.com/REGN2024.

Archived Events
Oct 52023 Oct 5, 2023

These slides contain the 60-week and 2-year (96-weeks) results from the Phase 3 PULSAR study of aflibercept 8 mg for nAMD. The presentation was given by Dr. Paolo Lanzetta at the 23rd EURETINA Congress on October 5, 2023.

Jul 292023 Jul 29, 2023

These slides contain the 2-year (96 weeks) results from the Phase 2/3 PHOTON study of aflibercept 8 mg for DME. The presentation was given by Diana V. Do, MD at the American Society of Retina Specialists Annual Meeting on July 29, 2023.

Jun 92023 10:30 AM EDT Jun 9, 2023 | 10:30 AM EDT

The 2023 Annual Meeting of Shareholders of Regeneron Pharmaceuticals, Inc. will be held on Friday, June 9, 2023, commencing at 10:30 a.m., Eastern Time, virtually via the Internet at www.virtualshareholdermeeting.com/REGN2023.